David Mack

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Mack

David Mack is recorded as Board Member at BioXcel Therapeutics, Inc. (BTAIQ). BioXcel Therapeutics, Inc. reported in an 8-K filed November 21, 2024 that David Mack was appointed Class I director, effective November 21, 2024.

“On November 21, 2024, the Board appointed David Mack to the Board, effective as of November 21, 2024.”

BioXcel Therapeutics, Inc. Form 8-K, filed November 21, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize David Mack's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

BioXcel Therapeutics, Inc. (BTAIQ)
Board Member

SEC 8-K

Current
2024-11-21–present

Company network

Recorded roles and call appearances connecting this person to public companies.

BioXcel Therapeutics, Inc.

BTAIQ

Current role

Board Member

2024-11-21–present

Leadership on record at BioXcel Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Dr. Rajiv Patni Board Member
June Bray Board Member
Michael Miller Board Member
Sandeep Laumas, M.D. Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Class I director BioXcel Therapeutics, Inc. (BTAIQ)
2024-11-21